Psychopharmacologic Treatment for Pediatric Anxiety Disorders

Peters, Todd E.; Connolly, Sucheta D.

doi:10.1016/j.chc.2012.07.007

Cited by 8 publications

(6 citation statements)

References 83 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A review of the treatment of problems associated with ADHD and maltreatment is beyond the scope of this article. There exists ample evidence‐based literature on the management of noted possible contributors to ADHD‐like symptoms, including anxiety (Peters & Connolly ; Reynolds et al . ), mood (Clark et al .…”

Section: Rates Of Adhd In Children Involved With Child Protection (Cps)mentioning

confidence: 99%

Diagnosing attention‐deficit hyperactivity disorder (ADHD) in children involved with child protection services: are current diagnostic guidelines acceptable for vulnerable populations?

Klein

Damiani-Taraba

Koster

et al. 2014

Child

View full text Add to dashboard Cite

Children involved with child protection services (CPS) are diagnosed and treated for attention-deficit hyperactivity disorder (ADHD) at higher rates than the general population. Children with maltreatment histories are much more likely to have other factors contributing to behavioural and attentional regulation difficulties that may overlap with or mimic ADHD-like symptoms, including language and learning problems, post-traumatic stress disorder, attachment difficulties, mood disorders and anxiety disorders. A higher number of children in the child welfare system are diagnosed with ADHD and provided with psychotropic medications under a group care setting compared with family-based, foster care and kinship care settings. However, children's behavioural trajectories change over time while in care. A reassessment in the approach to ADHD-like symptoms in children exposed to confirmed (or suspected) maltreatment (e.g. neglect, abuse) is required. Diagnosis should be conducted within a multidisciplinary team and practice guidelines regarding ADHD diagnostic and management practices for children in CPS care are warranted both in the USA and in Canada. Increased education for caregivers, teachers and child welfare staff on the effects of maltreatment and often perplexing relationship with ADHD-like symptoms and co-morbid disorders is also necessary. Increased partnerships are needed to ensure the mental well-being of children with child protection involvement.

show abstract

Section: Rates Of Adhd In Children Involved With Child Protection (Cps)mentioning

confidence: 99%

Diagnosing attention‐deficit hyperactivity disorder (ADHD) in children involved with child protection services: are current diagnostic guidelines acceptable for vulnerable populations?

Klein

Damiani-Taraba

Koster

et al. 2014

Child

View full text Add to dashboard Cite

show abstract

“…Relatedly, while SSRIs are approved to treat PTSD in adults, 12 there is less evidence supporting SSRIs for pediatric PTSD, likely explaining the lower proportion of children with PTSD initiating with an SSRI alone. 12,26 The variation observed in initial medication class by co-morbid psychiatric diagnoses was expected and potentially appropriate as medication selection should consider co-morbidities. 8 Still, almost a third of children with no recent co-morbid psychiatric diagnosis initiated with a non-SSRI anti-anxiety medication.…”

Section: Discussionmentioning

confidence: 98%

“…We defined anti-anxiety medications as medications with trial evidence of effectiveness in treating anxiety in adult or pediatric populations and also medications suggested as potential effective treatments for anxiety (Table 1, grouped into medication classes). 17,18,25,26 Children could have initiated anti-anxiety pharmacotherapy with two medication classes (e.g. SSRI+benzodiazepine); children initiating with >2 classes were excluded (0.3%).…”

Section: Methodsmentioning

confidence: 99%

Treating Pediatric Anxiety

Bushnell¹,

Compton²,

Dusetzina³

et al. 2018

J. Clin. Psychiatry

View full text Add to dashboard Cite

show abstract

“…Decisions may be influenced by the child's characteristics, parents' preferences, costs, and timing of onset (Walkup, 2009). Safety (Rynn et al, 2015) and potential risks associated with medications require consideration in the context of the individual and family (Peters & Connolly, 2012).…”

Section: Pharmacotherapymentioning

confidence: 99%

What steps to take? How to approach concerning anxiety in youth.

Kendall

Makover

Swan

et al. 2016

Clinical Psychology: Science and Practice

View full text Add to dashboard Cite

Anxiety in youth is a concern, and stepped care provides appropriate services for differential levels of distress and increases the number of youth able to receive services. Youth, and families, with mild anxiety benefit from print and Internet resources. Youth whose anxiety persists can receive direct guidance (e.g., computer‐assisted programs). A third step increases the intensity of services (e.g., therapy). Finally, for severely problematic anxiety, intensive programs may be needed. Throughout, it is important to monitor anxiety and related impairment as well as to take into account client and family characteristics. Research on interventions within each step has identified many to be efficacious, but studies are needed to examine the decision‐making features as well as the effectiveness of a stepped care approach.

show abstract

Psychopharmacologic Treatment for Pediatric Anxiety Disorders

Cited by 8 publications

References 83 publications

Diagnosing attention‐deficit hyperactivity disorder (ADHD) in children involved with child protection services: are current diagnostic guidelines acceptable for vulnerable populations?

Diagnosing attention‐deficit hyperactivity disorder (ADHD) in children involved with child protection services: are current diagnostic guidelines acceptable for vulnerable populations?

Treating Pediatric Anxiety

What steps to take? How to approach concerning anxiety in youth.

Contact Info

Product

Resources

About